21 related articles for article (PubMed ID: 36758682)
1. Prognostic Risk Models Using Epithelial Cells Identify β-Sitosterol as a Potential Therapeutic Target Against Esophageal Squamous Cell Carcinoma.
Zhang Z; Shang B; Mao X; Shi Y; Zhang G; Wang D
Int J Gen Med; 2024; 17():1193-1211. PubMed ID: 38559590
[TBL] [Abstract][Full Text] [Related]
2. The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating
Wang L; Meng Y; Xu JJ; Zhang QY
Mol Cancer Res; 2018 May; 16(5):857-868. PubMed ID: 29378908
[TBL] [Abstract][Full Text] [Related]
3. LAPTM4B promotes the progression of nasopharyngeal cancer.
Su Q; Luo H; Zhang M; Gao L; Zhao F
Bosn J Basic Med Sci; 2021 Jun; 21(3):305-312. PubMed ID: 32651973
[TBL] [Abstract][Full Text] [Related]
4. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.
Meng Y; Wang L; Xu J; Zhang Q
Mol Oncol; 2018 Mar; 12(3):373-390. PubMed ID: 29337428
[TBL] [Abstract][Full Text] [Related]
5. LAPTM4B-35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics.
Liu M; Yan R; Wang J; Yao Z; Fan X; Zhou K
Cancer Sci; 2022 Jun; 113(6):2022-2033. PubMed ID: 35381120
[TBL] [Abstract][Full Text] [Related]
6. Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma.
Su H; Xu T; Huang X; Zang S; Wang B; Huang Y; Liu J; Huang A
Pathol Res Pract; 2017 Dec; 213(12):1536-1541. PubMed ID: 29108920
[TBL] [Abstract][Full Text] [Related]
7. LAPTM4B: an oncogene in various solid tumors and its functions.
Meng Y; Wang L; Chen D; Chang Y; Zhang M; Xu JJ; Zhou R; Zhang QY
Oncogene; 2016 Dec; 35(50):6359-6365. PubMed ID: 27212036
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia.
Ghoshal Gupta S; Baumann H; Wetzler M
Leuk Res; 2008 Jul; 32(7):1005-14. PubMed ID: 18192010
[TBL] [Abstract][Full Text] [Related]
9. LAPTM4B promotes AML progression through regulating RPS9/STAT3 axis.
Huang Y; Peng M; Qin H; Li Y; Pei L; Liu X; Zhao X
Cell Signal; 2023 Jun; 106():110623. PubMed ID: 36758682
[TBL] [Abstract][Full Text] [Related]
10. STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia.
Bruserud Ø; Nepstad I; Hauge M; Hatfield KJ; Reikvam H
Expert Rev Hematol; 2015 Feb; 8(1):29-41. PubMed ID: 25374305
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
